Published in Cancer Weekly, February 21st, 2006
According to recent research from South Korea, "the purpose of this study was to determine whether a combination treatment of temozolomide with celecoxib is effective in the rat orthotopic glioma model."
"After stereotactic injection of C6/LacZ rat glioma cells into the Sprague Dawley rat brain, the rats were randomly assigned to 4 treatment groups (group 1, control treatment; group 2, celecoxib [25 mg/kg p.o. every day] alone; group 3, temozolomide [7.5 mg/kg i.p. for 5 days at 2nd week] alone; group 4, a combination of celecoxib and temozolomide)," said S.G. Kang...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.